No Detail Found!

Outcome of Pretreatment Regimens on Hemodynamic Parameters and Emergence during Electroconvulsive Therapy -a Study on Dexmedetomidine and Esmolol.

Author(s)
Dixitkumar B. Modh Department of Anesthesia, GMERS Medical College and Hospital, Dharpur Patan, Gujarat, India
Manthan P. Parmar Department of Anesthesia, GMERS Medical College and Hospital, Dharpur Patan, Gujarat, India
Shilpin Solanki Department of Anesthesia, GMERS Medical College and Hospital, Dharpur Patan, Gujarat, India
Roopa Sachidananda Department of Anesthesia, GMERS Medical College and Hospital, Dharpur Patan, Gujarat, India
Abstract
Aim: Present study was performed with an aim to observe the effect on hemodynamic parameters and emergence during electroconvulsive therapy using dexmedetomidine and esmolol as pretreatment regimens. Methodology: In this prospective study, we selected all patients undergoing ECT from January 2017 to February 2018 in our hospital by convenient sampling, and divided them as follows; Group C (Control Group): patients who did not receive any pretreatment. Group D (Dexmedetomidine Group): inj dexmedetomidine 0.5 µg/kg diluted with 10 ml normal saline and administered over 10 min and Group E (Esmolol Group): inj esmolol 1mg/kg diluted in 10 ml normal saline and administered over 2 min during preoxygenation. Pulse rate, systolic, diastolic blood pressure and SpO2 were measured at baseline value and compared after administration of drugs at various intervals. Results: We observed statistically significant reduction in mean heart rate and blood pressure in Group E, followed by Group D after administration of drugs. Highly significant rise in hemodynamic parameters (HR, SBP, DBP) from baseline were observed in Group C at 1, 3 and 5 min after ECT shock and returned to baseline value at 10 min of ECT current. Obeying commands and eye opening were significantly delayed in Group D when compared to Group C and Group E. (p = 0.05) Conclusion: Attenuation of hemodynamic parameters during ECT are effectively achieved by inj esmolol 1 mg/kg followed by inj dexmedetomidine 0.5 µg/kg, but dexmedetomidine produces delayed recovery and attenuates emergence agitation better than esmolol without affecting seizure duration or any other complications.
Publication Details
Page(s) 52-58
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 23, Issue: 1, Year: 2019

Request the full text from PASTIC

Keywords
Agitation, Dexmedetomidine, Esmolol, Electroconvulsive therapy
0

Citations

0

Downloads

69

Views